Recon Strategy
Contact

Insights

Fifteen+ years of
healthcare thinking

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Outcomes Based Arrangements in Biopharma

  • Biopharma , 
  • Payers , 
  • Institutional
Today’s advanced therapies target devastating diseases with high unmet need. Given the urgent medical need (and pressure from patient advocates), regulators increasingly must make decisions based on early, incomplete data when it comes to durability, real-world effectiveness, and cost-effectiveness – all while bearing costs that can exceed $1 million per patient.

Read more

Survivorship Is Expanding Cancer Care — How Are Oncology Providers Responding?

  • Providers , 
  • Digital

Read more

Recon speaks with AJMC on emerging outcomes data for high touch primary care models in commercial populations

  • In the News

Read more

AJMC: More frequent visits to primary care can save net $30-40 PMPM for top 20% highest risk commercial members

  • Payers , 
  • Providers

Read more

Recon analysis in AJMC demonstrates, for the first time for commercially covered patients, the value of risk-stratifying primary care visit frequency

  • In the News

Read more

Walmart Health didn’t test the opportunity in rural underserved markets

  • Providers

Read more

Amazon becomes a shopping facilitator for healthcare services (finally…)

Read more

Are some of Kaiser’s regional ambitions starting to pay off?

  • Payers , 
  • Providers

Read more

What’s so special about One Medical in the eyes of Amazon? A few quick thoughts

  • Providers , 
  • Digital , 

Read more

The coming site-of-care shock for infusions

  • Biopharma , 
  • Payers , 
  • Providers

Read more

The ongoing physician affiliation land grab in Pennsylvania’s Capital District

  • Providers

Read more

Optum opening new competitive terrain in Revenue Cycle Management

  • Payers , 
  • Providers

Read more

Profit engine swap-outs: How UPMC sustained itself after the Highmark decoupling

  • Payers , 
  • Providers

Read more

JAMA Network: Trends in the Concentration and Distribution of Health Care Expenditures in the US, 2001-2018

  • In the News

Read more

Iora Agonistes: High-touch primary care in Medicare Advantage is no sure bet after all

  • Providers

Read more

Four plausible rationales for incumbent hospitals to embrace hospital@home despite the potential to divert “heads from beds”

  • Providers

Read more

WMT’s MeMD acquisition: too small a play to make the difference

  • Providers

Read more

How much are Humana’s value-based care models really taking out of utilization?

  • Payers , 
  • Providers

Read more

Walmart Health: Will the fifth attempt at clinics be the charm?

  • Providers , 

Read more

A tale of two cities: Referral networks of orthopedic surgeons in Miami and Seattle

  • Providers , 
  • Digital

Read more